Login / Signup

Use of alpha-adrenergic antagonists for lower urinary tract symptoms is not associated with worsening cognitive function.

Fernanda Gabrigna BertoJ Andrew McClureJeffrey CampbellBlayne Welk
Published in: Neurourology and urodynamics (2024)
Alpha-adrenergic antagonists for LUTS do not appear to increase the risk of cognitive decline, offering reassurance to clinicians and patients.
Keyphrases
  • lower urinary tract symptoms
  • cognitive decline
  • benign prostatic hyperplasia
  • mild cognitive impairment
  • end stage renal disease
  • newly diagnosed
  • prognostic factors
  • patient reported outcomes